Nisa Investment Advisors Portfolio holdings
AUM
$22.2B
1-Year Return
21.03%
This Quarter Return
-2.49%
1 Year Return
+21.03%
3 Year Return
+95.61%
5 Year Return
+159.15%
10 Year Return
+382.87%
AUM
$13.1B
AUM Growth
-$526M
(-3.9%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
23.49%
Holding
2,902
New
100
Increased
687
Reduced
999
Closed
128
Top Buys
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$15M |
| 2 |
Costco
COST
|
$13.1M |
| 3 |
Truist Financial
TFC
|
$12.1M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$11.6M |
| 5 |
Walmart
WMT
|
$11.4M |
Top Sells
| 1 |
Apple
AAPL
|
$25.2M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$9.5M |
| 3 |
Meta Platforms (Facebook)
META
|
$9.47M |
| 4 |
iShares National Muni Bond ETF
MUB
|
$8.93M |
| 5 |
AT&T
T
|
$8.64M |
Sector Composition
| 1 | Technology | 24.76% |
| 2 | Healthcare | 11.96% |
| 3 | Financials | 11.53% |
| 4 | Consumer Discretionary | 9.24% |
| 5 | Industrials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Foghorn Therapeutics
FHTX
$326M
| $2.82K | ﹤0.01% |
563
+50
| +10% | +$250 |
|
2277
DMC Global
BOOM
$146M
| $2.81K | ﹤0.01% |
115
| – | – |
|
2278
Brookfield Renewable
BEP
$7.06B
| $2.78K | ﹤0.01% |
128
| – | – |
|
2279
Sunrun
RUN
$4.19B
| $2.76K | ﹤0.01% |
220
-535
| -71% | -$6.72K |
|
2280
TechnipFMC
FTI
$16B
| $2.75K | ﹤0.01% |
135
| – | – |
|
2281
QuidelOrtho
QDEL
$1.95B
| $2.7K | ﹤0.01% |
37
-4
| -10% | -$292 |
|
2282
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $2.67K | ﹤0.01% |
715
+55
| +8% | +$206 |
|
2283
Frontier Communications
FYBR
$9.33B
| $2.66K | ﹤0.01% |
170
-30
| -15% | -$470 |
|
2284
ESAB
ESAB
$7.15B
| $2.39K | ﹤0.01% |
34
| – | – |
|
|
DNMR
2285
DELISTED
Danimer Scientific, Inc.
DNMR
| $2.37K | ﹤0.01% |
29
| – | – |
|
2286
Kodiak Sciences
KOD
$556M
| $2.33K | ﹤0.01% |
1,295
+60
| +5% | +$108 |
|
2287
JetBlue
JBLU
$1.85B
| $2.3K | ﹤0.01% |
500
-49,079
| -99% | -$226K |
|
2288
Emergent Biosolutions
EBS
$404M
| $2.28K | ﹤0.01% |
670
-8,000
| -92% | -$27.2K |
|
2289
Sterling Infrastructure
STRL
$8.7B
| $2.28K | ﹤0.01% |
31
| – | – |
|
2290
Novartis
NVS
$251B
| $2.24K | ﹤0.01% |
22
| – | – |
|
2291
Codexis
CDXS
$218M
| $2.19K | ﹤0.01% |
1,160
-9,135
| -89% | -$17.3K |
|
2292
Virtus Investment Partners
VRTS
$1.31B
| $2.02K | ﹤0.01% |
10
| – | – |
|
2293
Rackspace Technology
RXT
$335M
| $2.01K | ﹤0.01% |
856
| – | – |
|
2294
Alcon
ALC
$39.6B
| $2K | ﹤0.01% |
26
| – | – |
|
2295
Doximity
DOCS
$13B
| $1.91K | ﹤0.01% |
90
-90
| -50% | -$1.91K |
|
2296
Microvast
MVST
$829M
| $1.89K | ﹤0.01% |
1,001
+900
| +891% | +$1.7K |
|
2297
ALX Oncology
ALXO
$65.3M
| $1.88K | ﹤0.01% |
392
+10
| +3% | +$48 |
|
2298
ESCO Technologies
ESE
$5.23B
| $1.88K | ﹤0.01% |
18
| – | – |
|
2299
Cable One
CABO
$922M
| $1.85K | ﹤0.01% |
3
| – | – |
|
2300
ICF International
ICFI
$1.75B
| $1.81K | ﹤0.01% |
15
| – | – |
|